Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TECH Techne Corporation

交易中 05-27 14:22:15 EDT

47.49

-0.48

-1.01%

最高49.37	最低47.22	成交量106.69万
今开48.69	昨收47.97	日振幅4.48%
总市值73.99亿	流通市值73.57亿	总股本1.56亿
成交额5,125万	换手率0.69%	流通股本1.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TECH","market":"US","secType":"STK","nameCN":"Techne Corporation","latestPrice":47.485,"timestamp":1779906128332,"preClose":47.97,"halted":0,"volume":1066887,"delay":0,"changeRate":-0.010110485720241806,"floatShares":154934058,"shares":155812701,"eps":0.694691,"marketStatus":"交易中","change":-0.485,"latestTime":"05-27 14:22:15 EDT","open":48.69,"high":49.37,"low":47.2201,"amount":51250256.728191,"amplitude":0.044818,"askPrice":47.51,"askSize":10,"bidPrice":47.46,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.694691,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779912000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":47.97,"dividendRate":0.006739,"preHourTrading":{"tag":"盘前","latestPrice":48.44,"preClose":47.97,"latestTime":"09:28 EDT","volume":230,"amount":11119.860139999999,"timestamp":1779888523060,"change":0.47,"changeRate":0.009798,"amplitude":0.030019},"postHourTrading":{"tag":"盘后","latestPrice":47.97,"preClose":47.97,"latestTime":"19:34 EDT","volume":31879,"amount":1529234.5968,"timestamp":1779838450971,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.521055,"impliedVol":0.5529,"impliedVolPercentile":0.7888},"requestUrl":"/m/hq/s/TECH/wiki","defaultTab":"wiki","newsList":[{"id":"2636584169","title":"NEXION TECH(08420)：应勤民获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2636584169","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636584169?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:29","pubTimestamp":1779276563,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH(08420)发布公告，自2026年5月20日起：杨振宇先生已辞任独立非执行董事;并不再担任审核委员会成员及薪酬委员会成员。应勤民先生已获委任为独立非执行董事、审核委员会成员及薪酬委员会成员。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B64QTZ34.USD","BK4588","LU2237957902.USD","BK4121","BK4585","08420","IE00B19Z6F94.USD","TECH","LU2237957811.SGD","BK1134","IE0034390439.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636966079","title":"MANYCORE TECH(00068)：稳定价格行动及稳定价格期结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2636966079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636966079?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:32","pubTimestamp":1779111156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MANYCORE TECH 发布公告，有关全球发售的稳定价格期间于2026年5月14日结束。稳定价格经办人于稳定价格期间并无就稳定价格而在市场买卖任何股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B19Z6F94.USD","TECH","BK4121","BK4588","BK1109","LU2237957902.USD","IE0034390439.USD","IE00B64QTZ34.USD","BK4585","BK1147","00068","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190054607","title":"异动解读 | Bio-Techne盘中大跌15.54%，因季度营收未达预期且美国学术经费削减导致需求下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1190054607","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190054607?lang=zh_cn&edition=full","pubTime":"2026-05-07 00:17","pubTimestamp":1778084245,"startTime":"0","endTime":"0","summary":"生物技术公司Bio-Techne今日盘中股价大幅下跌15.54%，引起了市场的广泛关注。消息面上，公司公布的第一季度财务业绩未达市场预期。业绩不及预期的主要原因是美国学术经费的削减，抑制了市场对其药物研发相关产品的需求。公司最大的蛋白质科学部门销售额下降1%，至2.262亿美元；诊断与基因组学部门收入也下降4%，至8560万美元，均未达到市场预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632602644","title":"MANYCORE TECH(00068)与金涌订立战略合作框架协议 就全球业务拓展、设立风险投资基金及资本市场合作达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2632602644","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632602644?lang=zh_cn&edition=full","pubTime":"2026-05-03 19:03","pubTimestamp":1777806192,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MANYCORE TECH 发布公告，本公司近日与金涌投资有限公司订立战略合作框架协议，订约方已就全球业务拓展、设立风险投资基金及资本市场合作达成战略合作。根据框架协议，金涌将利用弘毅投资涵盖全球家具供应链及消费行业的生态系统资源，协助本公司进行全球业务拓展，并提升订约方的国际竞争力及海外客户获取能力。此外，金涌将向本公司提供顾问及相关金融服务，以深化双方在资本市场及企业服务方面的合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B19Z6F94.USD","BK4585","TECH","00068","LU2237957811.SGD","IE00B64QTZ34.USD","BK1109","BK4121","LU2237957902.USD","IE0034390439.USD","BK1147","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1154855063","title":"财报前瞻｜Techne Corporation营收预计降0.14%，多方占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1154855063","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154855063?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:55","pubTimestamp":1777434901,"startTime":"0","endTime":"0","summary":"Techne Corporation将于2026年05月06日美股盘前发布最新财报，市场聚焦营收走势与费用节律变化对盈利质量的影响。市场一致预期本季度Techne Corporation营收为3.17亿美元，同比下降0.14%；调整后每股收益为0.54美元，同比增长5.12%；息税前利润约1.07亿美元，同比增长2.23%，当前未形成关于本季度毛利率、净利率或净利润的明确信息。主营来看，蛋白质科学板块上季度收入2.15亿美元，占比72.69%，产品谱系完整、复购属性强，结构性韧性是公司盈利的关键支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Techne Corporation营收预计降0.14%，多方占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629084893","title":"MANYCORE TECH(00068)因超额配股权获悉数行使而发行2409.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084893","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629084893?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:50","pubTimestamp":1777027822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MANYCORE TECH(00068)发布公告，于2026年4月23日根据悉数行使超额配股权而发行及配发2409.25万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","IE00B19Z6F94.USD","BK4121","TECH","00068","BK1147","BK4585","BK4588","LU2237957811.SGD","LU2237957902.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629474480","title":"ECI TECH(08013)发布中期业绩，股东应占溢利657万港元 同比增加44.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629474480","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629474480?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:08","pubTimestamp":1776866935,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ECI TECH(08013)发布截至2026年2月28日止6个月的中期业绩，该集团取得收益1.21亿港元，同比增加21.64%;期内溢利657万港元，同比增加44.65%;每股基本盈利0.411港仙。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","IE00B64QTZ34.USD","BK1187","TECH","LU2237957902.USD","IE00B19Z6F94.USD","BK4588","08013","BK4585","LU2237957811.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628724142","title":"MANYCORE TECH(00068.HK)悉数行使超额配股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724142","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628724142?lang=zh_cn&edition=full","pubTime":"2026-04-20 23:07","pubTimestamp":1776697623,"startTime":"0","endTime":"0","summary":"格隆汇4月20日丨MANYCORE TECH公告，公司宣布保荐人兼整体协调人已于2026年4月20日(星期一)悉数行使招股章程所述的超额配股权，涉及合共24,092,500股股份，占全球发售项下初步可供认购发售股份总数的约15%。　　超额配发股份将由公司按每股股份7.62港元发行及配发。　　公司将于全球发售的稳定价格期间结束后根据香港法例第571W章证券及期货规则第9条作出进一步公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260420/32158090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2237957902.USD","IE0034390439.USD","BK4121","BK4588","IE00B64QTZ34.USD","BK1147","TECH","BK4585","IE00B19Z6F94.USD","LU2237957811.SGD","00068"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2628726679","title":"MANYCORE TECH(00068)因购股权获行使而发行合共200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628726679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628726679?lang=zh_cn&edition=full","pubTime":"2026-04-20 21:35","pubTimestamp":1776692142,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MANYCORE TECH(00068)发布公告，根据2014年首次公开发售前股权激励计划行使购股权而发行合共200万股新股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","TECH","BK4121","IE00B64QTZ34.USD","BK4585","IE0034390439.USD","IE00B19Z6F94.USD","00068","BK1147","LU2237957902.USD","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190730239","title":"港股开盘 | 三大指数低开，MANYCORE TECH首日高开逾171%，长光辰芯高开80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190730239","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190730239?lang=zh_cn&edition=full","pubTime":"2026-04-17 09:21","pubTimestamp":1776388891,"startTime":"0","endTime":"0","summary":"4月17日，港股三大指数低开，恒指跌0.69%，科指跌0.72%。MANYCORE TECH上市首日高开逾171%，长光辰芯高开80%。","market":"hk","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f3a7317e60ae6d615eb15adcdf9b363f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","IE00B19Z6F94.USD","BK4588","HSI","VXUS","00068","BK1147","BK4585","LU2237957811.SGD","TECH","IE0034390439.USD","BK4121","IE00B64QTZ34.USD","LU2237957902.USD","03277"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627215505","title":"MANYCORE TECH(00068)以上限定价 香港公开发售获1590.56倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2627215505","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627215505?lang=zh_cn&edition=full","pubTime":"2026-04-16 21:05","pubTimestamp":1776344730,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MANYCORE TECH(00068)公布配发结果，公司全球发售约1.61亿股股份，香港公开发售占10%，国际发售占90%。最终发售价为每股7.62港元，全球发售净筹约10.92亿港元。每手500股，预期股份将于2026年4月17日(星期五)上午九时正在联交所开始买卖。其中，香港公开发售获1,590.56倍认购，国际发售获14.46倍认购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a4a10f5ae2b7a147a55ff156f72d08c4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TECH","00068","BK1147","BK4588","BK4121","IE00B19Z6F94.USD","IE0034390439.USD","LU2237957902.USD","IE00B64QTZ34.USD","LU2237957811.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626973389","title":"MANYCORE TECH(00068.HK)4月9日起招股 发售价将为每股6.72-7.62港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626973389","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626973389?lang=zh_cn&edition=full","pubTime":"2026-04-09 06:57","pubTimestamp":1775689022,"startTime":"0","endTime":"0","summary":"格隆汇4月9日丨MANYCORE TECH(00068.HK)发布公告，公司拟全球发售约1.61亿股H股，中国香港发售股份1606.2万股，国际发售股份约1.45亿股(以上可予重新分配及视乎超额配股权获行使与否而定)；2026年4月9日至4月14日招股，预期定价日为4月15日；发售价将为每股发售股份6.72-7.62港元，H股的每手买卖单位将为500股，摩根大通及建银国际为联席保荐人；预期H股将于2026年4月17日开始于联交所买卖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260409/32132162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE00B19Z6F94.USD","EWH","BK4585","TECH","LU2237957811.SGD","IE00B64QTZ34.USD","BK4121","LU2237957902.USD","IE0034390439.USD","IPOS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622720871","title":"NEXION TECH(08420)发布年度业绩 年内亏损385.2万港元 同比收窄75.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622720871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622720871?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:12","pubTimestamp":1774631549,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH(08420)发布截至2025年12月31日止年度业绩，该集团期内取得收益2388.8万港元，同比增加80.26%;年内亏损385.2万港元，同比收窄75.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1134","BK4121","IE0034390439.USD","LU2237957902.USD","BK4588","IE00B19Z6F94.USD","LU2237957811.SGD","TECH","IE00B64QTZ34.USD","08420","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620426814","title":"NEXION TECH(08420)发盈警 预期2025年公司权益持有人应占亏损大幅减少至不超过400万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620426814","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620426814?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:56","pubTimestamp":1773744995,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH 公布，该集团预期于2025年取得公司权益持有人应占亏损大幅减少至不超过400万港元，2024年公司权益持有人应占亏损则为约1469.5万港元。该业绩改善主要是由于该业务分部收入由2024财年约1325.2万港元增加约1063.6万港元或80.3% 至2025财年约2388.8万港元; 软件即服务分部(已终止)的分部业绩亏损由2024财年约729.1万港元减少至2025财年不超过30万港元，此乃主要由于为减少持续亏损而削减经营活动，及已确认的无形资产减值亏损拨备减少至零。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","IE00B64QTZ34.USD","TECH","LU2237957902.USD","IE00B19Z6F94.USD","BK1134","BK4588","08420","BK4585","LU2237957811.SGD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142929582","title":"Bio-Techne旗下Ella桌面免疫分析平台获欧盟CE-IVD认证 现已上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=1142929582","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142929582?lang=zh_cn&edition=full","pubTime":"2026-02-16 19:33","pubTimestamp":1771241600,"startTime":"0","endTime":"0","summary":"Bio-Techne公司宣布，其Ella桌面免疫分析平台已正式获得欧盟CE-IVD标志认证。这一重要里程碑意味着该平台现已获准在欧盟市场进行销售。Ella平台作为全自动化蛋白质生物标志物分析系统，能够实现样本到结果的全程自动化处理。此次获得CE-IVD认证，标志着该平台符合欧盟对体外诊断医疗设备的安全性与有效性要求，为欧洲医疗机构提供了更高效的免疫分析解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECH","IE0034390439.USD","BK4588","IE00B64QTZ34.USD","BK4585","BK4121","IE00B19Z6F94.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123232804","title":"异动解读 | 季度业绩超预期，Techne Corporation盘中大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123232804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123232804?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:05","pubTimestamp":1770217550,"startTime":"0","endTime":"0","summary":"生物技术公司Techne Corporation今日盘中大幅上涨5.14%，表现强劲。消息面上，公司公布了第二季度财报，其营收和利润均超出市场预期。业绩超预期主要得益于对其用于药物开发产品的强劲需求，特别是在大型制药公司这一最大终端市场，公司已连续第四个季度实现两位数增长。公司旗下的蛋白质科学部门销售额实现增长，而诊断和基因组学部门收入虽略有下降，但整体业绩仍展现出韧性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100810846","title":"Bio-Techne高管称公司美国学术业务小幅下滑，欧洲稳定增长部分抵消影响——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1100810846","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100810846?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:13","pubTimestamp":1770214395,"startTime":"0","endTime":"0","summary":"在电话会议中，Bio-Techne公司高管指出，其美国学术业务出现了小幅度的下滑。然而，这一下降趋势被欧洲市场持续且稳定的增长部分抵消。整体来看，不同区域的市场表现呈现出一种此消彼长的态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4585","IE00B19Z6F94.USD","IE0034390439.USD","TECH","BK4588","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148708265","title":"异动解读 | Techne Corporation盘前大涨5.04%，因季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1148708265","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148708265?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:52","pubTimestamp":1770213178,"startTime":"0","endTime":"0","summary":"生物技术公司Techne Corporation（股票代码：TECH）今日盘前股价大幅上涨5.04%，表现强劲。消息面上，公司公布了第二季度财报，其营收和利润均超出市场预期。具体数据显示，第二季度营收达到约2.96亿美元，高于分析师预估的2.90亿美元；调整后每股利润为46美分，也超过了预期的43美分。业绩超预期主要得益于对其用于药物开发产品的强劲需求，特别是在大型制药公司这一最大终端市场，公司已连续第四个季度实现两位数增长。这一积极的财务表现显著提振了投资者信心，从而推动了股价在盘前交易时段的大幅上扬。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162136183","title":"Bio-Techne推出完全确定成分的合成替代品，扩展3D干细胞与类器官培养产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1162136183","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162136183?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:32","pubTimestamp":1770031934,"startTime":"0","endTime":"0","summary":"Bio-Techne公司近日宣布，其3D干细胞与类器官培养产品线迎来重要扩展，推出了一种全新的、完全确定成分的合成培养基替代方案。这一创新产品的推出，旨在为研究人员提供更稳定、更可重复的培养环境，从而推动干细胞生物学和类器官研究领域的进一步发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B19Z6F94.USD","BK4588","IE0034390439.USD","TECH","IE00B64QTZ34.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593448135","title":"NEXION TECH(08420)拟出售SaaS业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2593448135","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593448135?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:08","pubTimestamp":1766401682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH 公布，于2025年12月22日，该公司拟向Muhammad Ridzuan Gurbaksh Bin Abdullah出售Big Focus及Rich Joy的全部股权，总代价为50万港元，将以现金方式支付。据悉，巨确为一间于香港注册成立的有限公司及Big Focus 的全资附属公司，主要从事投资控股;及湖南渌江为一间于中国注册成立的公司及巨确的全资附属公司，主要于中国从事SaaS业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","IE00B19Z6F94.USD","BK4588","BK1134","IE00B64QTZ34.USD","08420","BK4121","BK4585","TECH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.bio-techne.com","stockEarnings":[{"period":"1week","weight":0.055},{"period":"1month","weight":-0.1147},{"period":"3month","weight":-0.1711},{"period":"6month","weight":-0.2578},{"period":"1year","weight":0.0254},{"period":"ytd","weight":-0.1843}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-Techne Corporation于1981年7月17日在明尼苏达州成立。Bio-Techne及其子公司共同经营业务，为全球的研究、诊断和生物处理市场开发、制造和销售生命科学试剂、仪器和服务。凭借其深厚的产品组合和应用专业知识，公司销售生物过程和分子诊断的科学调查的组成部分，揭示特定疾病的性质、诊断、病因和进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.486486,"avgChangeRate":-0.01276},{"month":2,"riseRate":0.540541,"avgChangeRate":0.021391},{"month":3,"riseRate":0.5,"avgChangeRate":0.00866},{"month":4,"riseRate":0.578947,"avgChangeRate":0.020956},{"month":5,"riseRate":0.552632,"avgChangeRate":0.045672},{"month":6,"riseRate":0.540541,"avgChangeRate":0.031978},{"month":7,"riseRate":0.567568,"avgChangeRate":0.019417},{"month":8,"riseRate":0.513514,"avgChangeRate":0.015323},{"month":9,"riseRate":0.459459,"avgChangeRate":0.007298},{"month":10,"riseRate":0.594595,"avgChangeRate":0.023203},{"month":11,"riseRate":0.621622,"avgChangeRate":0.024016},{"month":12,"riseRate":0.594595,"avgChangeRate":0.017892}],"exchange":"NASDAQ","name":"Techne Corporation","nameEN":"Bio-Techne"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Techne Corporation(TECH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Techne Corporation,TECH,Techne Corporation股票,Techne Corporation股票老虎,Techne Corporation股票老虎国际,Techne Corporation行情,Techne Corporation股票行情,Techne Corporation股价,Techne Corporation股市,Techne Corporation股票价格,Techne Corporation股票交易,Techne Corporation股票购买,Techne Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Techne Corporation(TECH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}